The recurrence of digital ulcers in patients with systemic sclerosis after discontinuation of oral treprostinil

Journal of Rheumatology

Volumn 43, Issue 9, 2016, Pages 1665-1671

  Shah, Ami A ^a   Schiopu, Elena ^b   Chatterjee, Soumya ^c   Csuka, Mary Ellen ^d   Frech, Tracy ^e   Goldberg, Avram ^f   Spiera, Robert ^g   Peng, Stanford L ^h   McBride, Ryan J ^j   Cleveland, Jody M ^k   Steen, Virginia ⁱ  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g HOSPITAL FOR SPECIAL SURGERY   (United States)

^h BENAROYA RESEARCH INSTITUTE   (United States)

ⁱ GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k UNITED THERAPEUTICS CORPORATION   (United States)

more..

Author keywords

Digital ulcers; Raynaud phenomenon; Systemic sclerosis; Treprostinil diolamine

Indexed keywords

TREPROSTINIL; ANTIHYPERTENSIVE AGENT; PROSTACYCLIN;

ADULT; ARTICLE; DISEASE DURATION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FINGER ULCER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; TREATMENT DURATION; TREATMENT WITHDRAWAL; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPLICATION; FINGER; MIDDLE AGED; MULTICENTER STUDY; RAYNAUD PHENOMENON; SKIN ULCER; VASCULARIZATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; FINGERS; HUMANS; MALE; MIDDLE AGED; RAYNAUD DISEASE; RECURRENCE; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SKIN ULCER;

EID: 84984984880     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.151437     Document Type: Article

References (10)

1. Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J; Canadian Scleroderma Research Group. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Arthritis Care Res 2011;63:142-9.
2. Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al; EUSTAR Co-Authors. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.
3. Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TG, et al. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. BMJ 1989;298:561-4.
4. Torley HI, Madhok R, Capell HA, Brouwer RM, Maddison PJ, Black CM, et al. A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis 1991;50:800-4.
5. Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 1992;19:1407-14.
6. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA Jr, et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994;120:199-206.
7. Shah AA, Schiopu E, Hummers LK, Wade M, Phillips K, Anderson C, et al. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion. Arthritis Res Ther 2013;15:R54.
8. Seibold JR, Wigley FM, Schiopu E, Denton CD, Silver RM, Steen VD, et al. Digital ischemic ulcers in scleroderma treated with oral treprostinil diethanolamine: a randomized, double-blind, placebo-controlled, multicenter study [abstract]. Arthritis Rheum 2011;63 Suppl 10:2483.
9. ClinicalTrials.gov. Digital ischemic lesions in scleroderma treated with oral treprostinil diethanolamine (DISTOL-1). [Internet. Accessed May 25, 2016.] Available from: ClinicalTrials.gov/ct2/show/NCT00775463
10. Baron M, Chung L, Gyger G, Hummers L, Khanna D, Mayes MD, et al. Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis. Clinical Rheumatol 2014;33:207-14.